We are live on
!
Find out more
Aptevo Therapeutics
APVO
APVO
hedge funds and large institutions have $1.82M invested in Aptevo Therapeutics in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
19% less capital invested
Capital invested by funds: $2.24M → $1.82M (-$427K)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$97.6K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$34.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.32K |
| 4 |
MCC
Money Concepts Capital
Palm Beach Gardens,
Florida
|
-$16 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$8 |
